Vivo Capital’s Precision BioSciences DTIL Stock Holding History

Vivo Capital’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$29.3K	Hold	4,675	–	–	﹤0.01%	49
2026 Q2	$36.7K	Hold	4,675	–	–	﹤0.01%	47
2026 Q1	$25.7K	Hold	4,675	–	–	﹤0.01%	46
2025 Q4	$19.4K	Hold	4,675	–	–	﹤0.01%	47
2025 Q3	$25.8K	Hold	4,675	–	–	﹤0.01%	47
2025 Q2	$19.6K	Hold	4,675	–	–	﹤0.01%	42
2025 Q1	$22.3K	Hold	4,675	–	–	﹤0.01%	40
2024 Q4	$17.8K	Hold	4,675	–	–	﹤0.01%	40
2024 Q3	$41.9K	Hold	4,675	–	–	﹤0.01%	43
2024 Q2	$45.5K	Hold	4,675	–	–	﹤0.01%	42
2024 Q1	$63.4K	Hold	4,675	–	–	0.01%	42
2023 Q4	$51.2K	Hold	4,675	–	–	﹤0.01%	47
2023 Q3	$47.9K	Hold	4,675	–	–	0.01%	53
2023 Q2	$73.8K	Hold	4,675	–	–	0.01%	48
2023 Q1	$106K	Hold	4,675	–	–	0.01%	48
2022 Q4	$167K	Hold	4,675	–	–	0.02%	48
2022 Q3	$182K	Hold	4,675	–	–	0.02%	50
2022 Q2	$224K	Hold	4,675	–	–	0.02%	48
2022 Q1	$432K	Hold	4,675	–	–	0.03%	52
2021 Q4	$1.04M	Hold	4,675	–	–	0.06%	53
2021 Q3	$1.62M	Hold	4,675	–	–	0.07%	57
2021 Q2	$1.76M	Hold	4,675	–	–	0.08%	57
2021 Q1	$1.45M	Hold	4,675	–	–	0.05%	61
2020 Q4	$1.17M	Hold	4,675	–	–	0.05%	57
2020 Q3	$864K	Hold	4,675	–	–	0.05%	64
2020 Q2	$1.17M	Hold	4,675	–	–	0.08%	54
2020 Q1	$846K	Buy	+4,675	New	+$1.22M	0.08%	53
2019 Q3	–	Sell	-9,350	Closed	-$3.72M	–	15
2019 Q2	$3.72M	Hold	9,350	–	–	0.35%	37
2019 Q1	$5.04M	Buy	+9,350	New	+$4.96M	0.5%	37

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Bleichroeder LP New York $1.02B AUM 33% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Vivo Capital's DTIL Position: Q3 2026 in Review

Vivo Capital held its Precision BioSciences (DTIL) position steady in Q3 2026 at 4,675 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #49.

Vivo Capital first reported a position in DTIL in Q1 2019 and has held it in 29 quarters since. The position peaked at $5.04M in Q1 2019. 75 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

Vivo Capital held 4,675 shares of Precision BioSciences worth $29.3K as of Q3 2026.
Vivo Capital left its Precision BioSciences share count unchanged in Q3 2026.
Precision BioSciences made up ﹤0.01% of Vivo Capital's portfolio in Q3 2026, its #49 holding.
Vivo Capital first reported a position in Precision BioSciences in Q1 2019 and has held it in 29 quarters since.
Vivo Capital's Precision BioSciences position peaked at $5.04M in Q1 2019.
75 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on Vivo Capital's 13F filing for Q3 2026, filed 13 Nov 2026.